Potential antiviral properties of antiplatelet agents against SARS-CoV-2 infection: an in silico perspective

SARS-CoV-2 represents the causative agent of the current pandemic (COVID-19). The drug repurposing technique is used to search for possible drugs that can bind to SARS-CoV-2 proteins and inhibit viral replication. In this study, the FDA-approved antiplatelets are tested against the main protease and...

Descripción completa

Detalles Bibliográficos
Autores principales: Abosheasha, Mohammed A., El-Gowily, Afnan H., Elfiky, Abdo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435103/
https://www.ncbi.nlm.nih.gov/pubmed/34510337
http://dx.doi.org/10.1007/s11239-021-02558-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435103/
https://www.ncbi.nlm.nih.gov/pubmed/34510337
http://dx.doi.org/10.1007/s11239-021-02558-5

Ejemplares similares